Field Medical Presents Late Breaking Field PULSE Trial Data at AF Symposium 2026

CARDIFF-BY-THE-SEA, Calif., Feb. 5, 2026 /PRNewswire/ -- Field Medical, Inc., a clinical-stage medical technology company advancing pulsed field ablation (PFA) solutions for complex cardiac arrhythmias, today announced the presentation of late breaking clinical trial data from the first-in-human Field PULSE study at the 31st Annual International AF Symposium 2026, held February 5–7 in Boston.

Read the full press release here.